Call for papers: Exercise as medicine for metabolic dysfunction and obesity: eschewing generalities by defining specifics
Edited by Fred DiMenna
As a rally cry, “exercise is medicine” has united the exercise community. However, for exercise to be universally embraced as a viable alternative to pharmaceutical intervention, more than a captivating catchphrase is required. For example, it is well established that exercise can play an important role in combating the growing prevalence of obesity and associated metabolic disorders related to the oft-associated loss of insulin sensitivity. However, heretofore, the exercise programming variables that define the program that optimizes this positive influence have not been clarified. Pharmaceuticals are prescribed with research-based precision regarding medication type, dosage and route, time and frequency of administration. For exercise to represent an alternative to conventional medicine for the prevention/treatment of obesity and the associated metabolic disorders, similar evidence-based precision is required. The aim of this thematic series is to provide a forum within which research can be presented that establishes this foundation.
Submission is open to everyone, and all submitted manuscripts will be peer-reviewed through the regular journal review process. Manuscripts should be formatted according to the relevant journal submission guidelines and submitted via the online submission system. In the submission system please ensure that the correct thematic series title is chosen from the additional information tab. Please also indicate clearly in the covering letter which thematic series you are submitting to.
If you have any research you would like us to consider for inclusion in our cross-journal collection, please submit directly to one of the collaborating journals. Alternatively you can email your pre-submission queries to Clare.Partridge@biomedcentral.com
Collection published: 18 August 2017